Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz
Ventyx Biosciences shares surged 66% in premarket trading Wednesday after the Wall Street Journal reported Eli Lilly is in advanced talks to acquire the company for over $1 billion. The stock reached $16.70 before the bell, up from Tuesday’s $10.05 close. Neither company has confirmed a deal.